{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:24:39Z","timestamp":1771298679736,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,13]]},"DOI":"10.7759\/cureus.73599","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T14:35:51Z","timestamp":1731508551000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%\/Timolol 0.5% vs. Dorzolamide 2%\/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 Study"],"prefix":"10.7759","author":[{"given":"Purvi","family":"Bhagat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Singhania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Navare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohua","family":"Mazumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrima","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Shet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyani","family":"VKS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Nicholsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prachi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0220-6","article-title":"Glaucoma, \"the silent thief of sight\": patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria","volume":"16","author":"Abdull MM","year":"2016","unstructured":"Abdull MM, Chandler C, Gilbert C. Glaucoma, \"the silent thief of sight\": patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria. BMC Ophthalmol. 2016, 16:44. 10.1186\/s12886-016-0220-6","journal-title":"BMC Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11686","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison K","year":"2020","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020, 12:e11686. 10.7759\/cureus.11686","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2012.02.003","article-title":"Epidemiology of glaucoma: what's new?","volume":"47","author":"Cook C","year":"2012","unstructured":"Cook C, Foster P. Epidemiology of glaucoma: what's new?. Can J Ophthalmol. 2012, 47:223-6. 10.1016\/j.jcjo.2012.02.003","journal-title":"Can J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014, 121:2081-90. 10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7869\/djo.565","article-title":"Prevalence and associated risk factors of glaucoma in Aligarh, India - a population based study","volume":"31","author":"Ahmad A","year":"2020","unstructured":"Ahmad A, Ahmad SZ, Khalique N, Ashraf M, Alvi Y. Prevalence and associated risk factors of glaucoma in Aligarh, India - a population based study. Del J Ophthalmol. 2020, 31:36-40. 10.7869\/djo.565","journal-title":"Del J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1948_19","article-title":"Spectrum of Eye Disease in Diabetes (SPEED) in India: a prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus","volume":"68","author":"Behera UC","year":"2020","unstructured":"Behera UC, Bhattacharjee H, Das T, Gilbert C, Murthy GV, Rajalakshmi R, Pant HB. Spectrum of Eye Disease in Diabetes (SPEED) in India: a prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus. Indian J Ophthalmol. 2020, 68:S32-6. 10.4103\/ijo.IJO_1948_19","journal-title":"Indian J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.143927","article-title":"Relationship between systemic hypertension, perfusion pressure and glaucoma: a comparative study in an adult Indian population","volume":"62","author":"Deb AK","year":"2014","unstructured":"Deb AK, Kaliaperumal S, Rao VA, Sengupta S. Relationship between systemic hypertension, perfusion pressure and glaucoma: a comparative study in an adult Indian population. Indian J Ophthalmol. 2014, 62:917-22. 10.4103\/0301-4738.143927","journal-title":"Indian J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.074948","article-title":"A population based survey of the prevalence and types of glaucoma in rural West Bengal: the West Bengal Glaucoma Study","volume":"89","author":"Raychaudhuri A","year":"2005","unstructured":"Raychaudhuri A, Lahiri SK, Bandyopadhyay M, Foster PJ, Reeves BC, Johnson GJ. A population based survey of the prevalence and types of glaucoma in rural West Bengal: the West Bengal Glaucoma Study. Br J Ophthalmol. 2005, 89:1559-64. 10.1136\/bjo.2005.074948","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.73687","article-title":"An Indian perspective on primary angle closure and glaucoma","volume":"59 Suppl","author":"Sihota R","year":"2011","unstructured":"Sihota R. An Indian perspective on primary angle closure and glaucoma. Indian J Ophthalmol. 2011, 59 Suppl:S76-81. 10.4103\/0301-4738.73687","journal-title":"Indian J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181c4ac5b","article-title":"Glaucoma in India: estimated burden of disease","volume":"19","author":"George R","year":"2010","unstructured":"George R, Ve RS, Vijaya L. Glaucoma in India: estimated burden of disease. J Glaucoma. 2010, 19:391-7. 10.1097\/IJG.0b013e3181c4ac5b","journal-title":"J Glaucoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903124388","article-title":"Brinzolamide\/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension","volume":"10","author":"Holl\u00f3 G","year":"2009","unstructured":"Holl\u00f3 G, Bozkurt B, Irkec M. Brinzolamide\/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension. Expert Opin Pharmacother. 2009, 10:2015-24. 10.1517\/14656560903124388","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1874364100903020038","article-title":"Risk factors for glaucoma needing more attention","volume":"3","author":"Coleman AL","year":"2009","unstructured":"Coleman AL, Kodjebacheva G. Risk factors for glaucoma needing more attention. Open Ophthalmol J. 2009, 3:38-42. 10.2174\/1874364100903020038","journal-title":"Open Ophthalmol J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl A","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002, 120:1268-79. 10.1001\/archopht.120.10.1268","journal-title":"Arch Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin AL","year":"2007","unstructured":"Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007, 144:533-40. 10.1016\/j.ajo.2007.06.012","journal-title":"Am J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"Tsai JC","year":"2009","unstructured":"Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009, 116:S30-6. 10.1016\/j.ophtha.2009.06.024","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318218287f","article-title":"Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial","volume":"21","author":"Katz LJ","year":"2012","unstructured":"Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma. 2012, 21:460-8. 10.1097\/IJG.0b013e318218287f","journal-title":"J Glaucoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore S","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007, 120:713-9. 10.1016\/j.amjmed.2006.08.033","journal-title":"Am J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.179718","article-title":"Brinzolamide\/timolol versus dorzolamide\/timolol fixed combinations: a hospital-based, prospective, randomized study","volume":"64","author":"Galose MS","year":"2016","unstructured":"Galose MS, Elsaied HM, Macky TA, Fouad PH. Brinzolamide\/timolol versus dorzolamide\/timolol fixed combinations: a hospital-based, prospective, randomized study. Indian J Ophthalmol. 2016, 64:127-31. 10.4103\/0301-4738.179718","journal-title":"Indian J Ophthalmol"},{"key":"ref19","article-title":"Antiglaucoma pharmacotherapy","volume":"5","author":"T\u0103taru C","year":"2012","unstructured":"T\u0103taru C, Purc\u0103rea V. Antiglaucoma pharmacotherapy. J Med Life. 2012, 5:247-51.","journal-title":"J Med Life"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.04.011","article-title":"Intraocular pressure-lowering efficacy of brinzolamide 1%\/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%","volume":"115","author":"Kaback M","year":"2008","unstructured":"Kaback M, Scoper SV, Arzeno G, et al.. Intraocular pressure-lowering efficacy of brinzolamide 1%\/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%. Ophthalmology. 2008, 115:1728-34. 10.1016\/j.ophtha.2008.04.011","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31818fb434","article-title":"The safety and efficacy of brinzolamide 1%\/timolol 0.5% fixed combination versus dorzolamide 2%\/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension","volume":"18","author":"Manni G","year":"2009","unstructured":"Manni G, Denis P, Chew P, et al.. The safety and efficacy of brinzolamide 1%\/timolol 0.5% fixed combination versus dorzolamide 2%\/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. J Glaucoma. 2009, 18:293-300. 10.1097\/IJG.0b013e31818fb434","journal-title":"J Glaucoma"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00111-3","article-title":"Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies","volume":"44","author":"Silver LH","year":"2000","unstructured":"Silver LH, Brinzolamide Comfort Study Group. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Surv Ophthalmol. 2000, 44:141-5. 10.1016\/S0039-6257(99)00111-3","journal-title":"Surv Ophthalmol"},{"key":"ref23","unstructured":"Azarga eye drops UK SmPC. (2020). https.\/\/www.medicines.org.uk\/emc\/product\/6542\/smpc#gref."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/wics.131","article-title":"SAS","volume":"3","author":"Rodriguez RN","year":"2011","unstructured":"Rodriguez RN. SAS. WIREs Comp Stat. 2011, 3:1-11. 10.1002\/wics.131","journal-title":"WIREs Comp Stat"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(01)00974-6","article-title":"Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension","volume":"1","author":"Michaud JE","year":"2001","unstructured":"Michaud JE, Friren B, International Brinzolamide Adjunctive Study Group. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001, 1:235-43. 10.1016\/s0002-9394(01)00974-6","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S58293","article-title":"Efficacy and safety of brinzolamide\/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension","volume":"8","author":"Yoshikawa K","year":"2014","unstructured":"Yoshikawa K, Kozaki J, Maeda H. Efficacy and safety of brinzolamide\/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2014, 8:389-99. 10.2147\/OPTH.S58293","journal-title":"Clin Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s4088","article-title":"A patient preference comparison of Azarga\u2122 (brinzolamide\/timolol fixed combination) vs Cosopt\u00ae (dorzolamide\/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension","volume":"2","author":"Mundorf TK","year":"2008","unstructured":"Mundorf TK, Rauchman SH, Williams RD, Notivol R. A patient preference comparison of Azarga\u2122 (brinzolamide\/timolol fixed combination) vs Cosopt\u00ae (dorzolamide\/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2008, 2:623-8. 10.2147\/opth.s4088","journal-title":"Clin Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701353","article-title":"Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects","volume":"18","author":"Stewart WC","year":"2004","unstructured":"Stewart WC, Day DG, Stewart JA, Holmes KT, Jenkins JN. Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects. Eye (Lond). 2004, 18:905-10. 10.1038\/sj.eye.6701353","journal-title":"Eye (Lond)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83063-5","article-title":"Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting","volume":"22","author":"Barnebey H","year":"2000","unstructured":"Barnebey H, Kwok SY. Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting. Clin Ther. 2000, 22:1204-12. 10.1016\/S0149-2918(00)83063-5","journal-title":"Clin Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269085-efficacy-and-safety-of-a-fixed-dose-combination-of-brinzolamide-1timolol-05-vs-dorzolamide-2timolol-05-in-indian-patients-with-primary-open-angle-glaucoma-or-ocular-hypertension-a-randomized-phase-3-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T14:35:54Z","timestamp":1731508554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269085-efficacy-and-safety-of-a-fixed-dose-combination-of-brinzolamide-1timolol-05-vs-dorzolamide-2timolol-05-in-indian-patients-with-primary-open-angle-glaucoma-or-ocular-hypertension-a-randomized-phase-3-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.73599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}